#52 Long-term recharging experience in patients using the Axonics SNM System
Long-term recharging experience in patients using the Axonics SNM System
Padron O1, McCrery R2, Lane F3, Benson K4, Taylor C5, Blok B6, de Wachter S7, Pezzella A8, Gruenenfelder J9, Pakzad M10, Perrouin-Verbe M11, Van Kerrebroeck P12, Mangel J13, Peters K14, Kennelly M15, Shapiro A16, Lee U17, Comiter C18, Mueller M19, Goldman H20
1. Florida Urology Partners, Tampa, Florida, 2. Adult & Pediatric Urology & Urogynecology, Omaha, Nebraska, 3. University of California, Irvine, California, 4. Sanford Hospital, Sioux Falls, South Dakota, 5. Taylor Surgical Arts, Harrison, Arkansas, 6. Erasmus MC, Rotterdam, The Netherlands, 7. University Hospital Antwerpen, Edegem, Belgium, 8. Southern Urogynecology, West Columbia, South Carolina, 9. Orange County Urology Associates, Laguna Hills, California, 10. University College London Hospital, Marylebone, London, 11. CHU de Nantes Hotel Dieu, Nantes, France, 12. Maastricht University Medical Centre, Maastricht, The Netherlands, 13. MetroHealth, Cleveland, Ohio, 14. Beaumont Health, Royal Oak, Michigan, 15. Carolinas Healthcare System Charlotte, North Carolina, 16. Chesapeake Urology Research Associates, Owings Mills, Maryland, 17. Virginia Mason, Seattle, Washington, 18. Stanford University, Palo Alto, California, 19. Northwestern University, Chicago, Illinois, 20. Cleveland Clinic, Cleveland, Ohio
KEYWORDS: Incontinence, Urgency Urinary Incontinence, Neuromodulation
Sacral neuromodulation (SNM) is a guideline-recommended treatment for urinary dysfunctions and fecal incontinence [1]. The Axonics® System is the first rechargeable SNM System approved in United States, Europe, Canada and Australia to provide therapy for at least 15 years. Use of rechargeable SNM systems could potentially eliminate or significantly reduce the number of replacement surgeries required due to battery depletion of non-rechargeable neurostimulators. Further, the use of long-lived rechargeable systems could result in significant cost savings for healthcare systems [2]. The ARTISAN-SNM study treated urinary urgency incontinence (UUI) patients with the rechargeable Axonics System. Study participants’ long-term recharging experience is presented.
Read the full abstract text here: https://www.ics.org/2020/abstract/52